KL15

General Information


DRACP ID  DRACP00553

Peptide Name   KL15

Sequence  KRKLYKWFAHLIKGL

Sequence Length  15

UniProt ID  Not available

PubChem CID  Not available

Origin  membrane disrupting antimicrobial peptide KL15

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
SW480 Colon adenocarcinoma Carcinoma IC50=50 mg/ml MTT assay 24h 1
CaCo-2 Colon adenocarcinoma Carcinoma IC50=50 mg/ml MTT assay 24h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  H184B5F5/M10: IC50=150 μg/ml, testing time is 24h

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00553

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C94H149N25O17

Absent amino acids  CDEMNPQSTV

Common amino acids  K

Mass  215128

Pl  11.28

Basic residues  6

Acidic residues  0

Hydrophobic residues  7

Net charge  6

Boman Index  -1418

Hydrophobicity  -36

Aliphatic Index  110.67

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  6990

Absorbance 280nm  499.29

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 26147829

Title  Anti-proliferative effect on a colon adenocarcinoma cell line exerted by a membrane disrupting antimicrobial peptide KL15

Doi 10.1080/15384047.2015.1056407

Year  2014

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.